Brief: ROVI FY Revenue EUR 743.5 Million Vs. IBES Estimate EUR 732.8 Million

Laboratorios Farmaceuticos Rovi

25/02/2026 06:47

Feb 25 (Reuters) - ROVI FY free cash flow EUR 120 million.

FY EBIT EUR 185.8 million

FY EBITDA EUR 216.2 million

FY net income EUR 140.4 million